Arenavirus and West Nile Virus in Solid Organ Transplantation
Authors:
- N. SinghNSN. Singh
- M. E. LeviMLM. E. Levi
- the AST Infectious Diseases Community of PracticeTPthe AST Infectious Diseases Community of Practice
Open Access
- 6 March 2013
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 13 (s4) , 361-371
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Solid Organ Transplant–associated Lymphocytic Choriomeningitis, United States, 2011Emerging Infectious Diseases, 2012
- Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse modelVaccine, 2012
- West Nile Virus workshop: scientific considerations for tissue donorsCell and Tissue Banking, 2011
- Ribavirin for Lassa Fever Postexposure ProphylaxisEmerging Infectious Diseases, 2010
- Impact of rituximab‐associated B‐cell defects on West Nile virus meningoencephalitis in solid organ transplant recipientsClinical Transplantation, 2010
- mTOR regulates memory CD8 T-cell differentiationNature, 2009
- Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infectionBMC Infectious Diseases, 2009
- Lymphocytic Choriomeningitis in MichiganEmerging Infectious Diseases, 2006
- Treatment of West Nile Virus Encephalitis with Intravenous ImmunoglobulinEmerging Infectious Diseases, 2001
- Lassa FeverNew England Journal of Medicine, 1986